Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and Safety of Ivermectin and Albendazole Co-administration in School-aged Children and Adults Infected With Trichuris Trichiura: a Multi-country Randomized Controlled Trial

Trial Profile

Efficacy and Safety of Ivermectin and Albendazole Co-administration in School-aged Children and Adults Infected With Trichuris Trichiura: a Multi-country Randomized Controlled Trial

Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 12 Dec 2018

At a glance

  • Drugs Albendazole (Primary) ; Ivermectin (Primary)
  • Indications Trichuriasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2018 Planned initiation date changed from 1 Sep 2018 to 1 Apr 2019.
    • 10 Aug 2018 Planned initiation date changed from 1 Jun 2018 to 1 Sep 2018.
    • 22 May 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top